drugset / Trial / NCT00002154
A Study of Thioctic Acid and Deprenyl in HIV-Infected Patients With Dementia
Double-blindTreatment
Summary
The purpose of this study is to see if it is safe and effective to give thioctic acid and deprenyl (selegiline hydrochloride), alone or in combination, to HIV-infected patients who have mild to moderate dementia (a decline in their mental abilities).
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thioctic Acid | Unknown | — | — |
| Subject | deprenyl | Unknown | — | — |